MP21-16 ERBB2 OVEREXPRESSION IS RELEVANT TO THERAPEUTIC RESISTANCE AND POOR PROGNOSIS IN MUSCLE-INVASIVE BLADDER CANCER PATIENTS TREATED WITH CHEMORADIATION-BASED BLADDER-SPARING PROTOCOL

Muscle Invasive ◽

Bladder Sparing ◽

Erbb2 Overexpression

Significance of ERBB2 Overexpression in Therapeutic Resistance and Cancer-Specific Survival in Muscle-Invasive Bladder Cancer Patients Treated With Chemoradiation-Based Selective Bladder-Sparing Approach

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2014.05.043 ◽

2014 ◽

Vol 90 (2) ◽

pp. 303-311 ◽

Cited By ~ 11

Author(s):

Masaharu Inoue ◽

Fumitaka Koga ◽

Soichiro Yoshida ◽

Tomoki Tamura ◽

Yasuhisa Fujii ◽

...

Keyword(s):

Bladder Cancer ◽

Cancer Patients ◽

Invasive Bladder Cancer ◽

Therapeutic Resistance ◽

Cancer Specific Survival ◽

Muscle Invasive ◽

Bladder Sparing ◽

Erbb2 Overexpression

High levels of heat-shock factor 1 (HSF1) are associated with poor prognosis in muscle-invasive bladder cancer patients treated with chemoradiation-based bladder sparing protocol

10.1016/s1569-9056(19)31051-6 ◽

2019 ◽

Vol 18 (1) ◽

pp. e1460

Author(s):

T. Kijima ◽

R. Teramatsu ◽

S. Fukuda ◽

H. Fukushima ◽

S. Moriyama ◽

...

Keyword(s):

Bladder Cancer ◽

Heat Shock ◽

Cancer Patients ◽

Poor Prognosis ◽

Heat Shock Factor ◽

Invasive Bladder Cancer ◽

Heat Shock Factor 1 ◽

Muscle Invasive ◽

MP32-01 HIGH LEVELS OF HEAT-SHOCK FACTOR 1 (HSF1) ARE ASSOCIATED WITH POOR PROGNOSIS IN MUSCLE-INVASIVE BLADDER CANCER PATIENTS TREATED WITH CHEMORADIATION-BASED BLADDER SPARING PROTOCOL

The Journal of Urology ◽

10.1097/01.ju.0000555890.43105.5a ◽

2019 ◽

Vol 201 (Supplement 4) ◽

Author(s):

Toshiki Kijima* ◽

Ryu Teramatsu ◽

Shohei Fukuda ◽

Hiroshi Fukushima ◽

Shingo Moriyama ◽

...

Keyword(s):

Bladder Cancer ◽

Heat Shock ◽

Cancer Patients ◽

Poor Prognosis ◽

Heat Shock Factor ◽

Invasive Bladder Cancer ◽

Heat Shock Factor 1 ◽

Muscle Invasive ◽

924 Prediction of therapeutic resistance using ERBB2 expression status and Ki-67 labelling index in muscle-invasive bladder cancer patients treated with chemoradiation-based selective bladder-sparing approach

10.1016/s1569-9056(16)60926-0 ◽

2016 ◽

Vol 15 (3) ◽

pp. e924

Author(s):

M. Inoue ◽

F. Koga ◽

S. Yoshida ◽

H. Tanaka ◽

S. Kobayashi ◽

...

Keyword(s):

Bladder Cancer ◽

Cancer Patients ◽

Invasive Bladder Cancer ◽

Therapeutic Resistance ◽

Ki 67 ◽

Erbb2 Expression ◽

Muscle Invasive ◽

Bladder Sparing ◽

Expression Status

PD38-05 PREDICTIVE MODEL FOR THERAPEUTIC RESISTANCE USING ERBB2 EXPRESSION STATUS AND KI-67 LABELING INDEX IN MUSCLE-INVASIVE BLADDER CANCER PATIENTS TREATED WITH CHEMORADIOTHERAPY-BASED BLADDER-SPARING PROTOCOL

The Journal of Urology ◽

10.1016/j.juro.2016.02.1485 ◽

2016 ◽

Vol 195 (4S) ◽

Author(s):

Masaharu Inoue ◽

Fumitaka Koga ◽

Soichiro Yoshida ◽

Hajime Tanaka ◽

Shuichiro Kobayashi ◽

...

Keyword(s):

Bladder Cancer ◽

Predictive Model ◽

Cancer Patients ◽

Therapeutic Resistance ◽

Ki 67 ◽

Erbb2 Expression ◽

Muscle Invasive ◽

Bladder Sparing ◽

Expression Status

76 Risk factors for intravesical tumor recurrence in muscle-invasive bladder cancer patients treated with selective bladder-sparing approaches

10.1016/s1569-9056(13)60568-0 ◽

2013 ◽

Vol 12 (1) ◽

pp. e76-e77

Author(s):

F. Koga ◽

Y. Fujii ◽

J-I. Ishioka ◽

Y. Matsuoka ◽

N. Numao ◽

...

Keyword(s):

Risk Factors ◽

Bladder Cancer ◽

Cancer Patients ◽

Tumor Recurrence ◽

Invasive Bladder Cancer ◽

Muscle Invasive ◽

650 WHO ARE AT HIGH-RISK FOR CANCER DEATH AMONG MUSCLE-INVASIVE BLADDER CANCER PATIENTS TREATED WITH CHEMORADIATION-BASED BLADDER- SPARING PROTOCOLS?

10.1016/s1569-9056(11)60639-8 ◽

2011 ◽

Vol 10 (2) ◽

pp. 210

Author(s):

F. Koga ◽

M. Yokoyama ◽

J. Ishioka ◽

N. Numao ◽

K. Saito ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Cancer Patients ◽

Invasive Bladder Cancer ◽

Cancer Death ◽

Muscle Invasive ◽

High Ki-67 Expression Predicts Favorable Survival in Muscle-Invasive Bladder Cancer Patients Treated With Chemoradiation-Based Bladder-Sparing Protocol

Clinical Genitourinary Cancer ◽

10.1016/j.clgc.2015.03.002 ◽

2015 ◽

Vol 13 (4) ◽

pp. e243-e251 ◽

Cited By ~ 11

Author(s):

Kenji Tanabe ◽

Soichiro Yoshida ◽

Fumitaka Koga ◽

Masaharu Inoue ◽

Shuichiro Kobayashi ◽

...

Keyword(s):

Bladder Cancer ◽

Cancer Patients ◽

Invasive Bladder Cancer ◽

Ki 67 ◽

Muscle Invasive ◽

517 ErbB2 overexpression predicts chemoradiotherapy resistance and worse prognosis in muscle-invasive bladder cancer patients treated with induction chemoradiotherapy followed by partial or radical cystectomy

10.1016/s1569-9056(14)60509-1 ◽

2014 ◽

Vol 13 (1) ◽

pp. e517

Author(s):

M. Inoue ◽

F. Koga ◽

S. Yoshida ◽

T. Kijima ◽

Y. Nakanishi ◽

...

Keyword(s):

Bladder Cancer ◽

Cancer Patients ◽

Radical Cystectomy ◽

Invasive Bladder Cancer ◽

Induction Chemoradiotherapy ◽

Muscle Invasive ◽

Worse Prognosis ◽

Erbb2 Overexpression

Clinical outcomes of tetra-modality bladder sparing therapy incorporating consolidative partial cystectomy in muscle-invasive bladder cancer patients with hydronephrosis

10.1016/s1569-9056(19)30587-1 ◽

2019 ◽

Vol 18 (1) ◽

pp. e804-e805

Author(s):

M. Toide ◽

T. Kijima ◽

S. Fukuda ◽

H. Fukushima ◽

S. Moriyama ◽

...

Keyword(s):

Bladder Cancer ◽

Cancer Patients ◽

Clinical Outcomes ◽

Partial Cystectomy ◽

Invasive Bladder Cancer ◽

Muscle Invasive ◽